ArticleCNS drugs2023

Comment on: "Extended‑Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder".

Uday Pande et al.PubMed ↗Publisher ↗

No numbers read from the abstract.